Compare VANI & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VANI | SLNG |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.0M | 103.2M |
| IPO Year | 2014 | 2019 |
| Metric | VANI | SLNG |
|---|---|---|
| Price | $1.25 | $5.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.50 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 188.4K | 39.3K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2400.00 |
| EPS | N/A | ★ N/A |
| Revenue | $4,000,000.00 | ★ $68,245,000.00 |
| Revenue This Year | N/A | $8.66 |
| Revenue Next Year | N/A | $14.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $3.21 |
| 52 Week High | $1.92 | $6.36 |
| Indicator | VANI | SLNG |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 67.66 |
| Support Level | $1.21 | $4.76 |
| Resistance Level | $1.26 | $5.30 |
| Average True Range (ATR) | 0.06 | 0.37 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 55.85 | 74.05 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.